Clinical Trial Update: A Study to Evaluate the Ability of Lupron Depot to Enhance Immune Function Following Bone Marrow Transplantation [Phase 2]

View source ↗

Summary

Phase 2 study evaluating Lupron Depot to enhance immune function after bone marrow transplantation was terminated, with results posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma
• Mantle Cell Lymphoma
• Multiple Myeloma
• Non-hodgkin Lymphoma

Drugs mentioned

• LUPRON DEPOT (LEUPROLIDE ACETATE)

Snippet

Sponsor: Abbott | Conditions: Hodgkin Disease, Lymphoma, Non-Hodgkin | Phase 2 | Status: TERMINATED | Results posted: 2010-05-06